Pharma Pulse 12/19/24: The Lifespan of Mature Drugs in 2025, Women have a Greater Genetic Risk for PTSD & more

The Lifespan of Mature Drugs in 2025: Q&A with Kirsten Jacobs

PharmaLex’s chief strategy officer discusses strategies to improve monetization for these drugs.

Women have a Greater Genetic Risk for PTSD

Women are more than twice as likely to develop post-traumatic stress disorder than men, and a new study demonstrates for the first time that women have a great inherited biological risk.

Merck Snags Chinese Obesity Drug in Nearly $2 Billion Deal

Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion.

Wisp Partners with Nourish to Offer Patients on GLP-1s Personalized Nutrition Counseling

Wisp announced a strategic partnership with Nourish. Wisp patients can now access nutrition counseling services either through their health insurance or an exclusive self-pay rate, making it easier for women seeking a more holistic approach to weight management to access high-quality nutrition support at an affordable price.

Nicholas Saraceno on LinkedIn

Thank you for the educational chat, Vibhu Tewary. A real pleasure!

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs